Kim H W, Greenburg A G
Department of Surgery, Miriam Hospital, Providence, RI 02906, USA.
Artif Cells Blood Substit Immobil Biotechnol. 1997 Jan-Mar;25(1-2):121-33. doi: 10.3109/10731199709118904.
The exact mechanism of hemoglobin (Hb) associated vasoconstriction has not been elucidated. We investigated this problem using isolated superfused rat aortic rings with intact endothelium. Human stroma-free hemoglobin solution (SFH) at 2uM reversed vaso relaxation induced by 33uM acetylcholine (Ach). Further, pretreatment with 4uM SFH inhibited Ach(333uM) induced dilation. The SFH induced contraction was reversible by glyceryltrinitrate (GTN), a nitric oxide (NO) donor. Preincubation with a NO synthase inhibitor nitro-L-arginine-methyl ester (NAME, 0.4nM) caused almost complete inhibition of the Hb vasoactivity. Unlike SFH (ferrous oxyHb), prenitrosylated SFH (HbNO) or ferric Hb derivatives (e.g., metHb, HbCN) did not elicit vasoconstriction. The presence of 2uM SFH did not significantly reduce the vasodilatory effectiveness of endothelium independent vasodilators isoproteranol (ISO) and papaverine (PPV). These results suggest that a primary mechanism for Hb vasoconstrictor activity is ferrous Hb scavenging of endothelium derived NO, a signal for guanylate cyclase-cGMP mediated smooth muscle relaxation. Additionally, it appears that the Hb induced vasoactivities may be modulated with NO independent vasodilators.
血红蛋白(Hb)相关血管收缩的确切机制尚未阐明。我们使用具有完整内皮的离体灌流大鼠主动脉环来研究这个问题。2μM的人无基质血红蛋白溶液(SFH)可逆转33μM乙酰胆碱(Ach)诱导的血管舒张。此外,用4μM SFH预处理可抑制Ach(333μM)诱导的血管扩张。SFH诱导的收缩可被一氧化氮(NO)供体硝酸甘油(GTN)逆转。用NO合酶抑制剂硝基-L-精氨酸甲酯(NAME,0.4nM)预孵育几乎完全抑制了Hb的血管活性。与SFH(亚铁氧合血红蛋白)不同,亚硝基化SFH(HbNO)或高铁血红蛋白衍生物(如高铁血红蛋白、氰化血红蛋白)不会引起血管收缩。2μM SFH的存在并未显著降低非内皮依赖性血管舒张剂异丙肾上腺素(ISO)和罂粟碱(PPV)的血管舒张效果。这些结果表明,Hb血管收缩活性的主要机制是亚铁血红蛋白清除内皮衍生的NO,NO是鸟苷酸环化酶-cGMP介导的平滑肌舒张信号。此外,似乎Hb诱导的血管活性可能被非NO依赖性血管舒张剂调节。